Segment (Tables)

6 Months Ended

Jun. 30, 2026

Segment Reporting [Abstract]

Schedule of Reporting Segment Financial Information

The table below details the Company’s segment net loss, significant expenses, and other segment items (in thousands). The measure of segment assets is reported on the condensed consolidated balance sheets as total assets.

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Revenue	$	4	$	8	$	6	$	15
Less:
Technical operations	12,236		11,176		24,630		29,071
Clinical development	15,094		9,486		27,737		18,160
Support functions	5,211		5,672		10,849		14,127
Lease costs	3,715		4,377		7,424		8,823
Operations management	2,447		3,289		5,174		8,273
Research activities	2,775		2,460		5,185		5,990
Other segment items(1)	3,281		6,232		(12,085)		10,450
Net loss	$	44,755	$	42,684	$	68,908	$	94,879

1.Includes stock-based compensation, depreciation, other operating (income) loss, net, interest income, net, and other income, net. For the six months ended June 30, 2026, includes a $17.6 million gain associated with the settlement of the SPA put/call.